Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs35576914 | chr3:53092270 | G/A | 7.36E-6 | 174 | 25.08 | 30.87 | 11.78 | KM Plot |
PCPG | rs35583934 | chr2:107228174 | CTG/C | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs35586119 | chr8:121412984 | A/T | 3.41E-5 | 170 | 27.2 | 25.87 | 19.3 | KM Plot |
PCPG | rs35589199 | chr16:1713861 | G/GT | 0 | 178 | 25.53 | 18.75 | 2.93 | KM Plot |
PCPG | rs35609630 | chr9:136943128 | TA/T | 1.85E-5 | 178 | 25.53 | 21.55 | 28.57 | KM Plot |
PCPG | rs35609720 | chr16:88688058 | C/G | 0.000383 | 174 | 25.53 | 24.35 | 14.47 | KM Plot |
PCPG | rs35664136 | chr14:74414283 | T/C | 4.63E-6 | 173 | 25.17 | 29.7 | 10.43 | KM Plot |
PCPG | rs35664804 | chr14:74384474 | C/T | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs35673500 | chr16:1768227 | T/C | 1.76E-11 | 174 | 25.67 | 18.2 | 4.52 | KM Plot |
PCPG | rs35702854 | chr5:171531574 | C/CG | 0.000114 | 177 | 25.87 | 22.3 | 17.12 | KM Plot |
PCPG | rs35716271 | chr10:134396920 | T/A | 0.000319 | 171 | 25.08 | 27.27 | 2.23 | KM Plot |
PCPG | rs35717482 | chr2:242510982 | G/A | 8.88E-11 | 173 | 25.87 | 23.43 | 10.3 | KM Plot |
PCPG | rs35717780 | chr2:242586685 | CATG/C | 7.57E-11 | 175 | 25.67 | 24.7 | 10.3 | KM Plot |
PCPG | rs35720014 | chr3:52982110 | A/C | 6.56E-6 | 176 | 25.17 | 26.57 | 11.78 | KM Plot |
PCPG | rs35731596 | chr2:242590338 | A/G | 4.53E-11 | 178 | 25.87 | 23.67 | 10.3 | KM Plot |